Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
300 participants
OBSERVATIONAL
2024-03-19
2028-02-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Peripheral Immune System in Individuals With Schizophrenia
NCT05109065
Biomarkers in First Episode Schizophrenia
NCT02033382
Mental Health During the Whole Life Cycle of Community Patients with Schizophrenia
NCT05159349
Immunoinflammatory State Detection and Multimodal Brain Imaging and Electrophysiologic Changes in Schizophrenia
NCT06673966
Biomarkers Predictive of Thymic Evolution and Therapeutic Response at 2 Years in Patients With a First Psychotic Episode
NCT05384392
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
IBIS-PSY patients
Peripheral venipuncture blood sampling, as part of standard care procedures
Collection of 36 mL of blood
Interview with a psychiatrist
Research project data collection
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Peripheral venipuncture blood sampling, as part of standard care procedures
Collection of 36 mL of blood
Interview with a psychiatrist
Research project data collection
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient with one of the following diagnoses confirmed by a psychiatrist:
* Characterized depressive episode with psychotic features,
* Bipolar disorder type I
* Bipolar disorder type II
* Schizoaffective disorder
* Schizophrenia
* Schizophreniform disorder
* Patient under psychiatric care at Nantes University Hospital
* Patients weighing at least 45kg
* Patient affiliated to a social security scheme or beneficiary of such a scheme
* Patient who has given informed consent to participate in the study
Exclusion Criteria
* History of cancer in the last 5 years,
* Vaccination within the last 4 weeks,
* Acute or chronic infection,
* Medical history of organ transplant,
* Medical history of autoimmune disease,
* Hearing impairment making it impossible to complete study questionnaires,
* Patient under court protection
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
CR2TI, INSERM, UMR1064
UNKNOWN
Nantes University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anne Sauvaget
Role: PRINCIPAL_INVESTIGATOR
Nantes University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nantes University Hospital
Nantes, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RC23_0270
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.